VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
BCLI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
BCLIBrainstorm Cell Therapeutics Inc.
$0.90$10M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksBCLIQuarterly Cash Flow

Brainstorm Cell Therapeutics Inc. (BCLI) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Brainstorm Cell Therapeutics Inc. (BCLI) quarterly cash flow statement — complete operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

BCLI Cash Flow Statement

Quarterly statement

BCLI Cash Flow Statement

Brainstorm Cell Therapeutics Inc. (BCLI) cash flow statement — 24-year operating, investing & financing cash flows

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Cash from Operations-704K-895K-1.32M-740K-1.1M-3.5M-1.63M-1.05M-3.3M-1.68M-3.06M-3.29M-6.41M-6.78M-3.99M-4.65M-4.85M-6.13M-3.69M-5.51M
Operating CF Margin %------------957.73%--------
Operating CF Growth %36.12%74.44%19.07%29.39%66.6%-108.08%46.75%68.1%48.53%75.17%23.16%29.32%-32.14%-10.5%-8.08%15.61%24.92%-15.11%58.88%27.32%
Net Income-1.73M-3.85M-2.13M-2.43M-2.11M-2.9M-2.86M-2.97M-2.71M-2.54M-3.4M-5.58M-1.23M-5.33M-5.06M-5.02M-6.86M-7.04M-5.36M-6.19M
Depreciation & Amortization29K46K37K48K48K51K52K53K59K64K64K66K65K67K67K70K70K71K74K70K
Stock-Based Compensation570K2.24M133K143K157K503K717K208K178K194K170K0548K988K4K377K395K405K505K640K
Deferred Taxes00000000000000000000
Other Non-Cash Items1.74M00000-179K-282K-394K-411K-3K-2.39M-4.76M00646K-34K000
Working Capital Changes-1.31M670K637K1.5M799K-1.15M643K1.95M-434K1.01M107K4.62M-1.03M-2.5M1M-723K1.58M431K1.09M-28K
Change in Receivables5K-127K109K224K188K-5K-490K-2K149K133K121K-479K345K238K-579K-14K457K301K323K0
Change in Inventory00000000000000000000
Change in Payables-15K171K250K647K423K-800K717K1.48M-737K650K-264K-972K-1.26M-2.61M1.58M-171K1.1M722K870K961K
Cash from Investing000000012K000196K-12K4K2M1.04M-11K-12K-17K-1.3M
Capital Expenditures0000000001.68M00-18K000-1K-19K-9K-35K
CapEx % of Revenue--------------------
Acquisitions000000012K000000000000
Investments--------------------
Other Investing000000000-1.68M0004K2M1.04M-10K7K-8K-1.26M
Cash from Financing-2.15M898K1.25M780K313K2.7M3.09M1.06M04.37M2.54M3.35M7.1M5.3M3.23M238K000-34K
Debt Issued (Net)0-125K280K781K0-1.1M900K0000000000000
Equity Issued (Net)01.02M970K-1K313K3.35M685K1.06M04.37M2.54M3.35M7.1M5.3M3.23M238K000-34K
Dividends Paid00000000000000000000
Share Repurchases00000000000000000000
Other Financing-2.15M0000450K1.5M0000000000000
Net Change in Cash03K-70K40K-789K-801K1.46M19K-3.3M2.69M-524K78K676K-1.48M1.25M-3.37M-4.86M-6.15M-3.71M-6.84M
Free Cash Flow-704K-895K-1.32M-740K-1.1M-3.5M-1.63M-1.05M-3.3M-1.68M-3.06M-3.29M-6.43M-6.78M-3.99M-4.65M-4.85M-6.15M-3.7M-5.54M
FCF Margin %------------957.73%--------
FCF Growth %36.12%74.44%19.07%29.39%66.6%-108.08%46.75%68.1%48.67%75.17%23.16%29.32%-32.49%-10.16%-7.82%16.15%27.56%-14.86%58.91%29.04%
FCF per Share--0.08-0.12-0.08-0.10-0.41-0.26-0.18-0.62-0.35-0.71-0.98-2.18-2.56-1.63-1.90-1.99-2.53-1.52-2.29
FCF Conversion (FCF/Net Income)0.41x0.23x0.62x0.30x0.52x1.21x0.57x0.35x1.22x0.66x0.90x0.59x5.23x1.27x0.79x0.93x0.71x0.87x0.69x0.89x
Interest Paid00000000000000000000
Taxes Paid00000000000000000000